Parametric Portfolio Associates’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $26K | Sell |
36,219
-23,045
| -39% | -$16.5K | ﹤0.01% | 3655 |
|
2021
Q4 | $134K | Sell |
59,264
-30,193
| -34% | -$68.3K | ﹤0.01% | 3507 |
|
2021
Q3 | $258K | Sell |
89,457
-37,012
| -29% | -$107K | ﹤0.01% | 3356 |
|
2021
Q2 | $479K | Sell |
126,469
-68,028
| -35% | -$258K | ﹤0.01% | 3099 |
|
2021
Q1 | $658K | Sell |
194,497
-64,643
| -25% | -$219K | ﹤0.01% | 3358 |
|
2020
Q4 | $726K | Buy |
259,140
+199,283
| +333% | +$558K | ﹤0.01% | 3201 |
|
2020
Q3 | $150K | Sell |
59,857
-124,180
| -67% | -$311K | ﹤0.01% | 3727 |
|
2020
Q2 | $2.5M | Buy |
184,037
+83,340
| +83% | +$1.13M | ﹤0.01% | 2364 |
|
2020
Q1 | $763K | Buy |
100,697
+32,414
| +47% | +$246K | ﹤0.01% | 2950 |
|
2019
Q4 | $432K | Sell |
68,283
-145,437
| -68% | -$920K | ﹤0.01% | 3423 |
|
2019
Q3 | $838K | Buy |
213,720
+14,204
| +7% | +$55.7K | ﹤0.01% | 3112 |
|
2019
Q2 | $966K | Buy |
199,516
+64,835
| +48% | +$314K | ﹤0.01% | 3065 |
|
2019
Q1 | $1.1M | Sell |
134,681
-114,788
| -46% | -$940K | ﹤0.01% | 2980 |
|
2018
Q4 | $1.38M | Buy |
249,469
+227,364
| +1,029% | +$1.26M | ﹤0.01% | 2812 |
|
2018
Q3 | $195K | Sell |
22,105
-885
| -4% | -$7.81K | ﹤0.01% | 3768 |
|
2018
Q2 | $229K | Buy |
22,990
+5,626
| +32% | +$56K | ﹤0.01% | 3654 |
|
2018
Q1 | $165K | Sell |
17,364
-78,100
| -82% | -$742K | ﹤0.01% | 3797 |
|
2017
Q4 | $1.42M | Sell |
95,464
-9,734
| -9% | -$145K | ﹤0.01% | 2822 |
|
2017
Q3 | $2.07M | Buy |
105,198
+31,074
| +42% | +$611K | ﹤0.01% | 2564 |
|
2017
Q2 | $1.07M | Buy |
+74,124
| New | +$1.07M | ﹤0.01% | 2950 |
|
2016
Q4 | – | Sell |
-10,555
| Closed | -$96K | – | 3767 |
|
2016
Q3 | $96K | Buy |
+10,555
| New | +$96K | ﹤0.01% | 3685 |
|
2016
Q1 | – | Sell |
-23,807
| Closed | -$308K | – | 3966 |
|
2015
Q4 | $308K | Buy |
23,807
+12,731
| +115% | +$165K | ﹤0.01% | 3549 |
|
2015
Q3 | $107K | Sell |
11,076
-666
| -6% | -$6.43K | ﹤0.01% | 3181 |
|
2015
Q2 | $121K | Buy |
+11,742
| New | +$121K | ﹤0.01% | 3850 |
|